August 26, 2016 6:37 AM ET

Pharmaceuticals

Company Overview of Collegium Pharmaceutical, Inc.

Executive Profile

Michael T. Heffernan B.S. Pharm, R.Ph.

Founder, Chairman, Chief Executive Officer, President, Treasurer and Secretary, Collegium Pharmaceutical, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 9 different industries.

See Board Relationships
52$3,500,682
As of Fiscal Year 2015

Background

Mr. Michael T. Heffernan, also known as Mike, B.S. Pharm, R.Ph., Co-founded Collegium Pharmaceutical, Inc. in 2002 and has been its Chief Executive Officer and President since October 2003 and serves as its Chairman. Mr. Heffernan has been Senior Medical Advisor to Advocacy and Medical Education Efforts at Eli Lilly and Company since January 2013. He was Clinical Studies Ltd. (CSL) and served as its Chief Executive Officer and President from 1995 to 1999. He is a Proven ...

Corporate Headquarters

780 Dedham Street
Canton, Massachusetts 02021

United States

Phone: 781-713-3699
Fax: --

Board Members Memberships

Director
1998-Present
Chairman of the Board
2002-Present
Director and Member of Compensation Committee
2003-Present
Founder, Chairman, Chief Executive Officer, President, Treasurer and Secretary
2008-Present
Director, Chairman of Compensation Committee, Member of Investment Committee and Member of Special Committee
2016-Present
Director and Member of Compensation Committee

Education

BS
University of Connecticut

Other Affiliations

Annual Compensation

Salary$462,241
Bonus$375,000
Total Annual Compensation$837,241

Stocks Options

Restricted Stock Awards$633,984
All Other Compensation$14,168
Exercisable Options$79,117
Exercisable Options Value$1,761,678
Unexercisable Options$283,156
Unexercisable Options Value$5,541,201
Total Value of Options$7,302,878
Total Number of Options$362,273

Total Compensation

Total Annual Cash Compensation$1,089,699
Total Short Term Compensation$837,241
Other Long Term Compensation$648,152
Total Calculated Compensation$3,500,682
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Collegium Pharmaceutical, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.